Xeris Pharmaceuticals to acquire Strongbridge Biopharma for $267M in stock, CVRs
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Nvidia-Backed Recursion Pharmaceuticals Stock Is Up On Q1 Earnings: Everything You Need To Know
Recurs.....»»
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
EyePoint Pharmaceuticals reveals Phase 2 PAVIA trial results for Duravyu in non-proliferative diabetic retinopathy. Positive data showcases Duravyu's efficacy and safety profile. read more.....»»
Newly Listed Migraine-Focused AEON Biopharma Stock Plunges On Friday - Read Here Why
Preliminary results of AEON Biopharma's Phase 2 trial .....»»
Why Is NRx Pharmaceuticals Stock Falling After Data From Suicidal Bipolar Depression Study
NRX Pharmaceuticals announces Phase 2b/3 trial findings of NRX-101 vs. Lurasidone for Suicidal Bipolar Depression. read more.....»»
UMB will buy Heartland Financial in an all-stock deal worth about $2B
UMB Financial agreed to terms for its biggest acquisition yet, an all-stock deal to acquire Heartland Financial USA......»»
Jim Cramer: You"re "Dice Rolling" With This Biopharma Stock, But Vista Energy Is "A Good Situation"
"Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got big selling going on in AI stock Meta," he added. read more.....»»
Incyte Should Consider Significant Stock Buyback And Prioritize R&D, Analyst Recommends
Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow. Latest Ratings for INCY DateFirmActio.....»»
Skyhawk’s latest biopharma collaboration is worth up to $1.8B
Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc......»»
International Paper Acquires Packaging Firm DS Smith; Eyes Secondary Listing On London Stock Exchange
International Paper secures a $9.9 billion deal to acquire DS Smith Plc, fo.....»»
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors" Radars Today
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones I.....»»
Pieris stock rockets on record volume after Genentech collaboration valued at up to $1.4 billion
Shares of Pieris Pharmaceuticals Inc. rocketed 57.3% on massive volume in afternoon trading Tuesday, after the Boston-based biotechnology company announced a respiratory and ophthalmology collaboration with Roche Holding AG's .....»»
What"s Going On With Pieris Pharmaceuticals Stock Today?
Pieris Pharmaceuticals Inc (NASDAQ: PIRS) shares are trading higher by 57% at $2.91 after the company announced a respiratory and ophthalmology collaboration with Genentech. read more.....»»
Strongbridge downgraded to Hold at Craig-Hallum on Xeris acquisition
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Strongbridge Biopharma downgraded to Hold from Buy at Craig-Hallum
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Anebulo Pharmaceuticals started at buy with $15 stock price target at Benchmark
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Xeris Pharmaceuticals price target lowered to $9 from $14 at Mizuho
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Why Scopus BioPharma"s Stock Is Surging Today
Scopus BioPharma (NASDAQ:SCPS) shares are trading higher after the company announced the FDA has approved its IND application for CpG-STAT3siRNA, the company's distinctive immuno-oncology RNA therapy for the treatment of multiple cancers. read more.....»»
Enveric Biosciences to acquire MagicMed in all-stock transaction
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Performance Food Group to acquire Core-Mark for $2.5B in cash, stock
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Performance Food to acquire Core-Mark in cash-and-stock deal valued at $2.5 billion
Performance Food to acquire Core-Mark in cash-and-stock deal valued at $2.5 billion.....»»